Navigation Links
Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
Date:1/29/2008

41

Interest expense (73) (79) (273) (348) (1,430)

Change in fair value

of warrant liability 4 - (23) (149) (454)

Other expense - - (1,180) - (1,180)

Loss before tax

benefit (17,790) (11,773) (46,345) (41,167) (125,529)

Income tax benefit - - - - 695

Net loss (17,790) (11,773) (46,345) (41,167) (124,834)

Deemed dividend - - (19,424) - (19,424)

Preferred stock accretion (37) - (159) (351) (802)

Net loss attributable

to common

stockholders $(17,827) $ (11,773) $(65,928) $(41,518) $(145,060)

Net loss attributable

to common stockholders

per common share -

basic and diluted $ (19.77) $(0.53) $(89.58) $(3.14)

Weighted-average

common shares

outstanding - basic

and diluted 901,748 22,343,974 735,967 13,235,755

See accompanying notes to consolidated financial statements

Table 2

Amicus Therapeutics, Inc.

Reconciliation of GAAP to non-GAAP Measures for the
Statement of Operations Information for Three Months Ended December 31, 2007
(Unaudited)

(In thousands, except share and per share amounts)

Preferred

Stock Stock GAAP as

Non-GAAP Accretion Compensation Reported

Income Statement

Classifications:

Revenue $1,784 $1,784

Research and development (9,235) $- $(435) (9,670)

General and administrative (4,
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
2. Amicus Therapeutics to Host R&D Day
3. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
4. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
5. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
6. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
7. Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders
9. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
10. Nile Therapeutics Appoints Gregory W. Schafer to Board of Directors
11. Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... N.J. , June 1, 2015  The Val ... a national innovative science curriculum for high school students ... the 16 th annual LIFE Event (LPGA Pros ... Mountain Ridge Country Club in West Caldwell, ... the LPGA,s biggest stars raised more than $500,000 on ...
(Date:6/1/2015)... , June 1, 2015  Neogen Corporation (NASDAQ: NEOG ... Sterling Test House, a leading commercial food testing laboratory based ... acquired laboratory will serve as a base for the company,s ... Sterling Test House was incorporated in 1990, ... the food safety and water quality testing for major hotels ...
(Date:6/1/2015)... --  Epic Sciences, Inc. , a private diagnostics company ... and advance the treatment and management of cancer, announced ... its existing credit facility with Silicon Valley Bank ... of the facility from $5 million to $15 million ... April 1, 2019.  The availability of additional capital provides ...
(Date:6/1/2015)... 29, 2015 Research and Markets( ... the "2015 Strategies in the US ... their offering. This new 373-page ... comprehensive analysis of the POC clinical chemistry ... requirements, technological trends, competitive landscape, and emerging ...
Breaking Biology Technology:Val Skinner Foundation Announces Partnership With Discovery Education 2Neogen acquires India food safety company 2Epic Sciences Expands Silicon Valley Bank Credit Facility 2Epic Sciences Expands Silicon Valley Bank Credit Facility 3
... ... Spectrum Software announces key hire. Cindy Larkin has been hired as Director of ... her new role. , ... Southborough, MA (Vocus) November 3, 2009 -- Leading medical device and life sciences ...
... 2 BioBehavioral Diagnostics Company announced today that its ... was accepted via a rigorous peer-review process and included ... Meeting of the American Academy of Child and Adolescent ... Calvin R. Sumner, M.D., the company,s Chief Medical Officer ...
... 2 Microfluidics International Corporation (OTC Bulletin Board: MFLU), ... ended September 30, 2009. , (Logo: ... accomplishments: , Earned net income for the ... before interest, taxes, depreciation and amortization (EBITDA) Delivered ...
Cached Biology Technology:Medical Device Software Engineering Firm Full Spectrum Software Appoints Cindy Larkin to Director of Client Services 2Objective Measures of ADHD Symptoms Using the Quotient(TM) ADHD System May Reduce Cost of ADHD Drug Trials 2Objective Measures of ADHD Symptoms Using the Quotient(TM) ADHD System May Reduce Cost of ADHD Drug Trials 3Objective Measures of ADHD Symptoms Using the Quotient(TM) ADHD System May Reduce Cost of ADHD Drug Trials 4Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 2Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 3Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 4Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 5Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 6Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 7Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 8Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 9
(Date:5/14/2015)... NEW YORK , May 14, 2015 ... specializing in identity verification and online remote ... Instructure, a software-as-a-service (SaaS) company and creator ... Shared customers of the two companies will ... Proctortrack in Canvas. As a ...
(Date:5/11/2015)... 11, 2015 Curemark LLC, a privately held ... a new Phase III double blind, randomized, placebo-controlled clinical ... CM-AT, on all children ages 3-8 with Autism. Previously, ... III double blinded clinical trial for CM-AT in children ... the digestive enzyme chymotrypsin. This new trial will help ...
(Date:5/7/2015)... GOTHENBURG, Sweden , May 7, 2015 /PRNewswire/ ... new touch fingerprint sensors, FPC1022 and FPC1035, FPC,s ... FPC1022 and FPC1035 are mainly considered for integration ... decreased size gives smartphone OEMs increased possibilities to ... portfolio. The decreased size also improves possibilities for ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2
... Venus Express has detected the molecule hydroxyl on another ... an important new tool to unlock the workings of ... molecule, is made up of a hydrogen and oxygen ... reaches of the Venusian atmosphere, some 100 km above ...
... to stave off the cognitive deficits that occur with ... published in the second issue for May of the ... Care Medicine. Researchers examined the effects green tea ... were intermittently deprived of oxygen during 12-hour night cycles, ...
... the Great Lakes with things like trout and salmon would be ... the water, so it would be natural to assume that more ... in the April journal of Ecology by the Ecological Society of ... and trout to the area has not been good for the ...
Cached Biology News:Key molecule discovered in Venus's atmosphere 2Green tea compounds beat OSA-related brain deficits 2Restoring fish populations leads to tough choice for Great Lakes Gulls 2
Recorder, 6", 7 Day, 1 Pen, 0 to 100°C, 220V, 50/60 Hz, for 4520, Customer Installed...
... of the COP9 signalosome complex (CSN), a ... processes. The CSN complex is an essential ... by mediating the deneddylation of the cullin ... complex is also involved in phosphorylation of ...
... 96 well Magnetic-Ring Stand is designed for ... U-bottom microplates. The stand has a plastic ... microtiter plate footprint. The use of 96 ... and easy magnetic separation. With this magnetic ...
6B9...
Biology Products: